|
|
- 2017
鼻咽部肿瘤体积在中国西北非高发区鼻咽癌患者中的预后价值
|
Abstract:
摘要：目的 探索鼻咽部肿瘤体积在中国西北非高发区鼻咽癌患者中的预后价值。方法 将2004-2011年接受根治性放疗的393例鼻咽癌患者纳入本研究，所有患者均通过鼻咽部组织活检明确为鼻咽癌，观察总生存率和无远处转移生存率，采用ROC曲线确定肿瘤体积最佳界值，Kaplan-Meier比较患者生存差异，COX比例风险回归模型探索独立预后因素。结果 患者5年总生存率和无远处转移生存率分别为74.3%和73.5%。根据肿瘤体积最佳界值将患者分为≤23mL组和>23mL组，≤23mL组患者5年总生存率和无远处转移生存率明显高于>23mL组，差异有统计学意义(P<0.05)。多因素分析显示病理类型为分化亚型、肿瘤体积>23mL、N2～3为影响患者总生存率和无远处转移生存率的独立预后因素。结论 鼻咽部肿瘤体积是影响中国西北非高发区鼻咽癌患者生存的独立预后因素。
ABSTRACT: Objective To investigate the prognostic value of primary tumor volume in non-endemic patients with nasopharynx carcinoma in northwest China. Methods A total of 393 patients were enrolled in the study and all the patients had been identified with nasopharynx squamous cell carcinoma by biopsy. Overall survival (OS) and distant metastasis free survival (DMFS) were the primary endpoints. The cut-off of tumor volume was identified by ROC curves. Survival results were analyzed by the Kaplan-Meier curve. Independent prognostic factors were identified by COX proportional hazards regression model. Results The 5-year OS and DMFS for all the patients were 74.3% and 73.5%. 23mL was considered as the optimal cut-off value according to the ROC curves, and then the patients were divided into two groups (≤23mL and >23mL). Patients with tumor volume ≤23mL had significantly better 5-year OS and DMFS than those with tumor volume >23mL (P<0.05). The independent prognostic factors for DMFS and OS included WHO histological type, tumor volume >23mL and N2-3 (P<0.05). Conclusion Primary tumor volume is an independent prognostic factor for survival of nasopharyngeal carcinoma patients in northwest China
| [1] | SUN X, SU S, CHEN C, et al. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities[J]. Radiother Oncol, 2014, 110(3):398-403. |
| [2] | SZE WM, LEE AW, YAU TK, et al. Primary tumor volume of nasopharyngeal carcinoma: prognostic significance for local control[J]. Int J Radiat Oncol, 2004, 59(1):21-27. |
| [3] | LEE CC, HO HC, LEE MS, et al. Primary tumor volume of nasopharyngeal carcinoma: significance for survival[J]. Auris Nasus Larynx, 2008, 35(3):376-380. |
| [4] | ZWEIG MH, CAMPBELL G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine[J]. Clin Biochem, 1993, 39(4):561-577. |
| [5] | ZHOU JY, CHONG VF, KHOO JB, et al. The relationship between nasopharyngeal carcinoma tumor volume and TNM T-classification: a quantitative analysis[J]. Eur Arch Otorhinolaryngol, 2007, 264(2):169-174. |
| [6] | ZENG L, TIAN Y, SUN X, et al. Late toxicities after intensity-modulated radiotherapy for nasopharyngeal carcinoma: patient and treatment-related risk factors[J]. Br J Cancer, 2014, 110(1):49-54. |
| [7] | MILAS L, HUNTER N, PETERS LJ. The tumor bed effect: dependence of tumor take, growth rate, and metastasis on the time interval between irradiation and tumor cell transplantation[J]. Int J Radiat Oncol, 1987, 13(3):379-383. |
| [8] | GUO R, SUN Y, YU XL, et al. Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?[J]. Radiother Oncol, 2012, 104(3):294-299. |
| [9] | AIROLD M, GABRIELE AM, GARZARO M, et al. Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population[J]. Radiother Oncol, 2009, 92(1):105-110. |
| [10] | DEMIRCI S, KAMER S, KARA G, et al. Does the prognosis of nasopharyngeal cancer differ among endemic and non-endemic regions?[J]. Acta Otolaryngol, 2011, 131(8):852-860. |
| [11] | STENMARK MH, MCHUGH JB, SCHIPPER M, et al. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis[J]. Int J Radiat Oncol, 2014, 88(3):580-588. |
| [12] | FENG M, WANG W, FAN Z, et al. Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy[J]. Radiat Oncol, 2013, 5(8):208-218. |
| [13] | HUANG Q, LI F, LIU X, et al. Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy[J]. Nat Med, 2011, 17(7):860-866. |
| [14] | BOSCOLO-RIZZO P, TIRELLI G, MANTOVANI M, et al. Non-endemic locoregionally advanced nasopharyngeal carcinoma: long-term outcome after induction plus concurrent chemoradiotherapy in everyday clinical practice[J]. Eur Arch Otorhinol, 2015, 272(11):3491-3498. |
| [15] | ZANG J, LI C, ZHAO LN, et al. Prognostic model of death and distant metastasis for nasopharyngeal carcinoma patients receiving 3DCRT/IMRT in nonendemic area of China[J]. Medicine, 2016, 95(21):e3794. |
| [16] | CHEN C, FEI Z, PAN J, et al. Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy[J]. Jpn J Clin Oncol, 2011, 41(4):537-542. |
| [17] | LEE H, AHN YC, OH D, et al. Tumor volume reduction rate during adaptive radiation therapy as a prognosticator for nasopharyngeal cancer[J]. Cancer Res Treat, 2016, 48(2):537-545. |
| [18] | WANG R, TAN Y, WANG X, et al. Prognoses and long-term outcomes of nasopharyngeal carcinoma in Han and Uyghur patients treated with intensity-modulated radiotherapy in the Xinjiang Autonomous Region of China[J]. PLoS One, 2014, 9(11):e111145. |
| [19] | WU Z, SU Y, ZENG RF, et al. Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy[J]. J Cancer Res Ther, 2014,140(1):69-76. |
| [20] | JOHNSON CR, THAMES HD, HUANG DT, et al. The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography[J]. Int J Radiat Oncol, 1995, 33(2):281-287. |
| [21] | CHONG VF, ZHOU JY, KHOO JB, et al. Correlation between MR imaging-derived nasopharyngeal carcinoma tumor volume and TNM system[J]. Int J Radiat Oncol, 2006, 64(1):72-76. |
